2025 · 1st Quarter (Jan 1 - Mar 31)

SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)

Filed by TARPLIN, DOWNS & YOUNG, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 21, 2025
Income: $60,000.00
Expenses: Not reported
Registrant: TARPLIN, DOWNS & YOUNG, LLC
Client: SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION)
Filing UUID: ff9b4f23-9db8-409a-98b4-763e13bbd13a
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

IRA, transparency, vaccines, coverage and access

HCR · Health Issues

IRA, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD

BUD · Budget/Appropriations

federal budget issues

TAX · Taxation/Internal Revenue Code

orphan drug tax credit, vaccine policy

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.